| Prev Close | 10.48 |
| Day Low/High | 10.41 / 10.69 |
| 52 Wk Low/High | 6.27 / 14.63 |
| Avg Volume | 171.30K |
| Exchange | NASDAQ |
| Shares Outstanding | 47.14M |
| Market Cap | 494.02M |
| EPS | -2.90 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Conference Call Scheduled for Tuesday, August 8, 2017 at 8:30 a.m. ET
Investors eyeing a purchase of Karyopharm Therapeutics Inc stock, but tentative about paying the going market price of $9.34/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2018 put at the $7.50 strike, which has a bid at the time of this writing of 85 cents.
Earnings and Fed speakers are on tap in the next few days.
The most recent short interest data has been released for the 05/31/2017 settlement date, which shows a 351,835 share increase in total short interest for Karyopharm Therapeutics Inc , to 2,991,079, an increase of 13.33% since 05/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Enrollment Projected To Be Complete in 2018; Top-Line Data Expected in 2019
Phase 2b SADAL Data Also Selected for Poster Presentation at ICML 2017
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Conference Call Scheduled for Thursday, May 4, 2017 at 8:30 a.m. ET
Investors eyeing a purchase of Karyopharm Therapeutics Inc stock, but tentative about paying the going market price of $11.72/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $7.50 strike, which has a bid at the time of this writing of 65 cents.
Here's a technical look at how to play six stocks trending higher with strong volume.
The most recent short interest data has been released for the 03/31/2017 settlement date, which shows a 316,239 share increase in total short interest for Karyopharm Therapeutics Inc , to 2,483,391, an increase of 14.59% since 03/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Medidata (NASDAQ:MDSO) and clinical-stage pharmaceutical company Karyopharm Therapeutics (NASDAQ:KPTI) today announced an expanded partnership to bring novel machine-learning technology and targeted risk-based monitoring...
